Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Study sheds light on the role of immune cells in fat tissue inflammation and obesity

Fat tissue, for as much as it's been vilified, is an incredibly complex and essential bodily organ involved in energy storage and hormone production, among other functions.

10 Oct 2023

Black Chokeberry (Aronia melanocarpa) diabetes benefits: Hope or hype?

Researchers compared the effects of fermented and non-fermented Aronia melanocarpa berries on glycemic markers in Type 2 Diabetes Mellitus patients. Despite the berries' high antioxidant potential and past studies suggesting benefits, this rigorous trial found no significant impact on waist circumference, insulin sensitivity, or glucose levels.

10 Oct 2023

Hybrid closed-loop technology could be game-changing for pregnant women with type 1 diabetes

For pregnant women with type 1 diabetes, a technology giving insulin doses as informed by a smartphone algorithm, helps them better manage their blood sugars, compared to traditional insulin pumps or multiple daily injections, according to a new randomized trial published in The New England Journal of Medicine and presented at the European Association for the Study of Diabetes (EASD) meeting.

10 Oct 2023

The critical role of model interpretation in diabetes decision support systems

The importance of tools used to interpret the output of predictive models in type 1 diabetes (T1D) management.

10 Oct 2023

Health experts redefine cardiovascular disease risk, prevention and management

Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association's flagship journal Circulation.

9 Oct 2023

Precision medicine for gestational diabetes management

Precision markers to predict effective lifestyle and pharmacological interventions to manage Gestational Diabetes Mellitus.

9 Oct 2023

Is there an association between psoriasis onset and risk of autoimmune disease?

Researchers evaluated new-onset autoimmune disease risk among individuals with new-onset psoriatic illness.

9 Oct 2023

Itchy skin, tingling hands or slow-healing cuts may signal hidden diabetes

Everyday skin problems could have a more sinister cause, warns a blood testing expert. Itchy skin, tingling hands or a cut that takes a while to heal are usually given a quick scratch or a sticking plaster. However, they are also little-known symptoms of type 2 diabetes.

9 Oct 2023

The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes

Researchers investigate whether ribavirin and pleconaril could stimulate endogenous insulin production among individuals with incident type 1 diabetes.

8 Oct 2023

BU professor receives grant to study endothelial cell health in cardiometabolic disease

Naomi Hamburg, MD, the Joseph A. Vita Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine, has been awarded a five-year, $3.7 million grant from the National Heart, Lung and Blood Institute for her research study, "Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease."

6 Oct 2023

Machine learning can simplify lung cancer screening process

Machine learning models to identify the simplest way to screen for lung cancer have been developed by researchers from UCL and the University of Cambridge, bringing personalized screening one step closer.

6 Oct 2023

Sarcopenia doubles risk of cardiovascular death in people with diabetes

New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) shows that low muscle mass is associated with a two-fold risk of death from cardiovascular disease in individuals with diabetes.

6 Oct 2023

New research sheds light on metabolic problems faced by transgender people

The latest data on the metabolic problems faced by trans people are presented at a session at this year's Annual Meeting of the European Association for the Study of Diabetes (Hamburg 2-6 October).

6 Oct 2023

A telehealth model to support remote diabetes self-care

Researchers develop and test the effectiveness of a Virtual Diabetes Specialty Clinic (VDiSC), a virtual model facilitating comprehensive diabetes care remotely.

6 Oct 2023

GLP-1 weight loss drugs linked to heightened GI risks, says new study

Study from JAMA reveals that users of GLP-1 agonists, recent drugs for weight management, show a heightened risk of gastrointestinal complications like intestinal obstruction, gastroparesis, and pancreatitis. Though these effects are rare, those considering these drugs for weight loss should weigh the benefits against potential risks, especially if not using them for diabetes.

5 Oct 2023

New technology helps pregnant women with type 1 diabetes to better manage blood sugar levels

For pregnant women with type 1 diabetes, a technology giving insulin doses, as informed by a smartphone algorithm, helps them better manage their blood sugars compared with traditional insulin pumps or multiple daily injections, according to a new randomized trial published in The New England Journal of Medicine (NEJM) and presented at the European Association for the Study of Diabetes (EASD) meeting in Hamburg (2-6 October).

5 Oct 2023

GLP-1 agonists linked to higher risk for gastrointestinal complications

They're being hailed as an effective way to lose weight, but diabetes drugs like Ozempic may come with a heightened risk of severe gastrointestinal problems.

5 Oct 2023

Automated insulin delivery could be a game-changer for pregnant women with type 1 diabetes

Automated insulin delivery should be rolled out to pregnant women with type 1 diabetes - according to researchers at the University of East Anglia.

5 Oct 2023

The metabolic effects of endocrine therapy on diabetes mellitus in breast cancer survivors

Researchers discuss the history of endocrine therapies, highlights their adverse metabolic effects, and emphasizes the need for better biomarkers of diabetes.

5 Oct 2023

New drug tirzepatide equally effective in early-onset and later-onset type 2 diabetes

Tirzepatide is as effective at treating early-onset type 2 diabetes (T2D), a more aggressive form of the condition that normally responds less well to treatment, as it is at treating T2D diagnosed later in life, new research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has found.

4 Oct 2023

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Study sheds light on the role of immune cells in fat tissue inflammation and obesity

Black Chokeberry (Aronia melanocarpa) diabetes benefits: Hope or hype?

Hybrid closed-loop technology could be game-changing for pregnant women with type 1 diabetes

The critical role of model interpretation in diabetes decision support systems

Health experts redefine cardiovascular disease risk, prevention and management

Precision medicine for gestational diabetes management

Is there an association between psoriasis onset and risk of autoimmune disease?

Itchy skin, tingling hands or slow-healing cuts may signal hidden diabetes

The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes

BU professor receives grant to study endothelial cell health in cardiometabolic disease

Machine learning can simplify lung cancer screening process

Sarcopenia doubles risk of cardiovascular death in people with diabetes

New research sheds light on metabolic problems faced by transgender people

A telehealth model to support remote diabetes self-care

GLP-1 weight loss drugs linked to heightened GI risks, says new study

New technology helps pregnant women with type 1 diabetes to better manage blood sugar levels

GLP-1 agonists linked to higher risk for gastrointestinal complications

Automated insulin delivery could be a game-changer for pregnant women with type 1 diabetes

The metabolic effects of endocrine therapy on diabetes mellitus in breast cancer survivors

New drug tirzepatide equally effective in early-onset and later-onset type 2 diabetes

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in